Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancer

被引：0
|
作者：
Kim, Woosook [1 ]
Fu, Na [1 ]
Duddempudi, Phaneendra [2 ]
Dubeykovskaya, Zinaida [3 ]
Almo, Steven [2 ]
Guha, Chandan [2 ]
Lederman, Seth [4 ]
Wang, Timothy [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Albert Einstein Coll Med, New York, NY USA
[3] NYU, New York, NY USA
[4] Tonix Pharmaceut Inc, New York, NY USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-6640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6640
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
    Bezman, Natalie A.
    Jhatakia, Amy
    Kearney, Alper Y.
    Brender, Ty
    Maurer, Mark
    Henning, Karla
    Jenkins, Misty R.
    Rogers, Amy J.
    Neeson, Paul J.
    Korman, Alan J.
    Robbins, Michael D.
    Graziano, Robert F.
    BLOOD ADVANCES, 2017, 1 (12) : 753 - 765
  • [2] PD-1 BLOCKADE ENHANCES THE EFFICACY OF ELOTUZUMAB IN MOUSE TUMOR MODELS
    Bezman, N.
    Jhatakia, A.
    Kearney, A.
    Brender, T.
    Maurer, M.
    Sum, C.
    Lei, M.
    Waggie, K.
    Postelnek, J.
    Henning, K.
    Jenkins, M.
    Rogers, A.
    Neeson, P.
    Korman, A.
    Robbins, M.
    Graziano, R.
    HAEMATOLOGICA, 2016, 101 : 161 - 162
  • [3] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
    Zhao, M.
    Guo, W.
    Xu, Q.
    Sun, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1856 - 1856
  • [4] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
    Zhao, Mingxia
    Guo, Wenjie
    Wu, Yuanyuan
    Yang, Chenxi
    Zhong, Liang
    Deng, Guoliang
    Zhu, Yuyu
    Liu, Wen
    Gu, Yanhong
    Lu, Yin
    Kong, Lingdong
    Meng, Xiangbao
    Xu, Qiang
    Sun, Yang
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (02) : 304 - 315
  • [5] Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma
    Kim, Sun Hye
    Li, Man
    Trousil, Sebastian
    Zhang, Yaqing
    di Magliano, Marina Pasca
    Swanson, Kenneth D.
    Zheng, Bin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (08) : 1740 - 1748
  • [6] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
    Mingxia Zhao
    Wenjie Guo
    Yuanyuan Wu
    Chenxi Yang
    Liang Zhong
    Guoliang Deng
    Yuyu Zhu
    Wen Liu
    Yanhong Gu
    Yin Lu
    Lingdong Kong
    Xiangbao Meng
    Qiang Xu
    Yang Sun
    ActaPharmaceuticaSinicaB, 2019, 9 (02) : 304 - 315
  • [7] Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV
    Zhang, C.
    Wu, S.
    Xue, X.
    Li, M.
    Qin, X.
    Li, W.
    Han, W.
    Zhang, Y.
    CYTOTHERAPY, 2008, 10 (07) : 711 - 719
  • [8] Anti-tumor activity of a novel anti-human PD-1 antibody BGB-A317 in mouse models
    Song, Xiaomin
    Tang, Zhiyu
    Zhang, Tong
    Guo, Mingming
    Gong, Wenfeng
    Liu, Yong
    Zhang, Ningning
    Zhang, Yilu
    Zhang, Yanjuan
    Ma, Jie
    Song, Jing
    Li, Kang
    Wang, Lai
    CANCER RESEARCH, 2016, 76
  • [9] The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
    Zhao, Zihan
    Liu, Siyang
    Sun, Rui
    Zhu, Wenjie
    Zhang, Yulin
    Liu, Tianyao
    Li, Tianhang
    Jiang, Ning
    Guo, Hongqian
    Yang, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] PD-1 BLOCKADE ADMINISTERED BEFORE OR AT THE TIME OF T CELL ACTIVATION ENHANCES ANTI-TUMOR IMMUNITY
    Moseman, Jena
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A492 - A492
12345